ProgressImage ProgressImage
Novartis India Ltd
Pharmaceuticals - Multinational
BSE Code 500672 border-img ISIN Demat INE234A01025 border-img Book Value 331.23 border-img NSE Symbol NOVARTIND border-img Div & Yield % 0 border-img Market Cap ( Cr.) 4042.13 border-img P/E 41.34 border-img EPS 39.6 border-img Face Value 5
ParticularsMar 2026
()
Mar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
INCOME :       
Sales Turnover 376.96390.09366.84413.52486.66453.73
Excise Duty 0.000.000.000.000.000.00
Net Sales 376.96390.09366.84413.52486.66453.73
Other Income 38.7741.9661.6858.1133.1933.09
Stock Adjustments 12.21-3.75-9.86-2.359.12-10.74
Total Income 427.94428.30418.66469.28528.97476.08
EXPENDITURE :       
Raw Materials 210.58199.07189.98199.34187.26135.88
Power & Fuel Cost 0.110.140.180.350.530.53
Employee Cost 21.0818.7222.9635.64101.89108.51
Other Manufacturing Expenses 9.598.185.0012.5831.1533.51
Selling & Administrative Expenses 47.3959.7465.5582.78144.40128.11
Miscellaneous Expenses 6.329.078.0515.4053.089.66
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 295.07294.92291.72346.09518.31416.20
Operating Profit 132.87133.38126.94123.1910.6659.88
Interest 1.260.771.491.754.837.68
Gross Profit 131.61132.61125.45121.445.8352.20
Depreciation 1.952.192.616.069.6512.16
Profit Before Tax 129.66130.42122.84115.38-3.8240.04
Tax 34.9529.9637.631.68-0.4422.62
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 1.53-0.440.0210.340.34-3.48
Reported Net Profit 93.18100.9085.19103.36-3.7220.90
Extraordinary Items -0.020.141.990.17-44.680.03
Adjusted Net Profit 93.20100.7683.20103.1940.9620.87
Adjustment below Net Profit 1.420.971.213.118.19-6.09
P & L Balance brought forward 768.98728.84759.72677.94698.16708.04
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 61.7361.73117.2824.6924.6924.69
P & L Balance carried down 801.85768.98728.84759.72677.94698.16
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 500.00500.00500.00950.00200.00200.00
Dividend Per Share(Rs) 25.0025.0025.0047.5010.0010.00
Earnings Per Share-Unit Curr 37.7640.8834.5241.88-1.518.47
Earnings Per Share(Adj)-Unit Curr 37.7640.8834.5241.88-1.518.47
Book Value-Unit Curr 331.37318.06301.79314.29280.27288.16
Book Value(Adj)-Unit Curr 331.37318.06301.79314.29280.27288.16
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement   |    CDSL MyEasi   |    TRAI Notice on UCC   |    SEBI Risk Disclosure   |    Investor Notice

Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

x
x
×
Let's Chat
imsl-img
close
refresh